Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82−0.17 (-8.42%)
Close on Nov 17, 2026Market cap $2.65MP/E –Yield –
Nexentis Technologies total assets
Total assets on the balance sheet at the end of each period.
Nexentis Technologies's total assets was $18.69M at Jun 30, 2026. For fiscal 2025 it was $20.41M, up 273.4% from the year before. The highest annual figure on record is $20.41M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.41M | +273.4% |
| FY2024 | Dec 31, 2024 | $5.47M | -24.6% |
| FY2023 | Dec 31, 2023 | $7.24M | +11.6% |
| FY2022 | Dec 31, 2022 | $6.49M | -14.5% |
| FY2021 | Dec 31, 2021 | $7.60M | +1004.8% |
| FY2020 | Dec 31, 2020 | $687.65K | +3.5% |
| FY2019 | Dec 31, 2019 | $664.67K | -22.6% |
| FY2018 | Dec 31, 2018 | $859.21K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.69M | +141.1% |
| Q1 FY2026 | Mar 31, 2026 | $16.40M | +122.7% |
| Q4 FY2025 | Dec 31, 2025 | $20.41M | +273.4% |
| Q3 FY2025 | Sep 30, 2025 | $11.03M | +89.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.75M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.37M | +17.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.47M | -24.6% |
| Q3 FY2024 | Sep 30, 2024 | $5.82M | +10.9% |
| Q2 FY2024 | Jun 30, 2024 | $7.48M | +21.4% |
| Q1 FY2024 | Mar 31, 2024 | $6.27M | +14.5% |
| Q4 FY2023 | Dec 31, 2023 | $7.24M | +11.6% |
| Q3 FY2023 | Sep 30, 2023 | $5.25M | -33.4% |
| Q2 FY2023 | Jun 30, 2023 | $6.16M | +14.3% |
| Q1 FY2023 | Mar 31, 2023 | $5.47M | -17.3% |
| Q4 FY2022 | Dec 31, 2022 | $6.49M | -14.5% |
| Q3 FY2022 | Sep 30, 2022 | $7.89M | -10.8% |
| Q2 FY2022 | Jun 30, 2022 | $5.39M | -47.5% |
| Q1 FY2022 | Mar 31, 2022 | $6.62M | +651.6% |
| Q4 FY2021 | Dec 31, 2021 | $7.60M | +1004.8% |
| Q3 FY2021 | Sep 30, 2021 | $8.84M | +1415.5% |
| Q2 FY2021 | Jun 30, 2021 | $10.27M | +2813.3% |
| Q1 FY2021 | Mar 31, 2021 | $880.79K | +85.3% |
| Q4 FY2020 | Dec 31, 2020 | $687.65K | +3.5% |
| Q3 FY2020 | Sep 30, 2020 | $583.36K | -32.1% |
| Q2 FY2020 | Jun 30, 2020 | $352.68K | – |
| Q1 FY2020 | Mar 31, 2020 | $475.34K | – |
| Q4 FY2019 | Dec 31, 2019 | $664.67K | – |
| Q4 FY2018 | Dec 31, 2018 | $859.21K | – |
See a number that looks wrong?